Suzuken reports extraordinary gain from investment securities sales

Suzuken Co., Ltd. announced an extraordinary gain from the partial sale of investment securities, effective from May to October 2025. This action aligns with the Corporate Governance Code and the company's partially revised policy on cost of capital and stock price-conscious management, disclosed on May 13, 2025. The company conducted a review and reduction of its cross-shareholdings.

The sales involved four listed securities held by the company, resulting in a total gain on sale of investment securities of 15,567 million yen. Of this amount, 514 million yen was recorded as an extraordinary gain during the consolidated cumulative period of the first quarter of the fiscal year ending March 31, 2026.

This extraordinary gain is expected to be recorded in the consolidated financial results for the fiscal year ending March 31, 2026. However, the impact of this gain has already been factored into the "Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2026," disclosed on May 13, 2025, and therefore, no change to the earnings forecast is anticipated at this time.